Less-invasive, laparascopic colon surgery appears to be safer

NewsGuard 100/100 Score

German researchers say that minimally invasive colorectal surgery using the laparascope could reduce post-surgery complications.

According to the researchers, when compared to traditional surgery, the laparascopic procedure caused less inflammation and placed less stress on the immune system.

The team from Ludwig-Maximilians University in Munich, used laparoscopic surgery on 35 patients undergoing colorectal surgery, while another 35 patients received conventional surgery.

Lead researcher Dr. Matthias W. Wichmann says that even though both sets of patients experienced post-surgical inflammation, the levels were significantly higher in people who had undergone conventional operations.

However, they said the levels of natural killer cells, white blood cells that attack foreign bodies or abnormal cells, were significantly higher in people who had laparoscopic surgery, which suggests a stronger immune system.

The Society of Laparoendoscopic Surgeons has more information about laparoscopic surgery.

The findings are published in the July issue of Archives of Surgery.

http://archsurg.ama-assn.org/ and http://www.sls.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify increased brain tumor risk with specific contraceptive use